EUCTR2007-005717-19-FIActive, not recruitingNot Applicable
akritsin ja tiatsididiureetin yhteiskäytön vaikutus kaliumpitoisuuteen - Lakritsi ja hypokalemia
Oulu University Hospital Department of Internal Medicine0 sitesStarted: October 30, 2007Last updated:
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 2
asix effect in kidney transplant patientsKidney transplant.IRCT2016042023559N3Tabriz University of Medical Sciences80
Completed
Phase 4
Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control TrialMalariaNCT00832754Kintampo Health Research Centre, Ghana3,063
Completed
Phase 2
Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission TherapyAcute Promyelocytic LeukemiaNCT01404949Memorial Sloan Kettering Cancer Center17
Terminated
Phase 2
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaLeukemiaMyelodysplastic SyndromesNCT00118196Medical University of South Carolina1
Completed
Phase 4
Phase IV clinical trial of CEDARCURE(R)SLIT-tablet and MITICURE(R)SLIT-tablet.Allergic rhinitisJPRN-jRCT1080223956TORII PHARMACEUTICAL CO., LTD.109